×
Adocia EBIT 2016-2024 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Adocia ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Adocia EBIT 2016-2024 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Adocia ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$213.1B
Amgen (AMGN)
$159.1B
Gilead Sciences (GILD)
$134.7B
Vertex Pharmaceuticals (VRTX)
$117.7B
Bristol Myers Squibb (BMY)
$95B
CSL (CSLLY)
$81.2B
GSK (GSK)
$74.1B
Regeneron Pharmaceuticals (REGN)
$58.9B
Alnylam Pharmaceuticals (ALNY)
$41.8B
Argenex SE (ARGX)
$34.6B
BioNTech SE (BNTX)
$26.2B
Royalty Pharma (RPRX)
$20B
Insmed (INSM)
$19.5B
Biogen (BIIB)
$18B
Illumina (ILMN)
$15B
Genmab (GNMSF)
$14.2B
Genmab (GMAB)
$13.9B
Incyte (INCY)
$13B
Exelixis (EXEL)
$12.1B
Moderna (MRNA)
$12B
BioMarin Pharmaceutical (BMRN)
$10.8B
QIAGEN (QGEN)
$10.7B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10.3B
Exact Sciences (EXAS)
$9.1B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.3B
Bio-Techne Corp (TECH)
$7.9B
Roivant Sciences (ROIV)
$7.8B
Legend Biotech (LEGN)
$7.8B